The company's high liabilities and decreasing ROCE are worri...
The company's high liabilities and decreasing ROCE are worrisome. Reinvestment has not led to significant sales growth. These trends are not typical for multi-baggers, suggesting investors may need to look elsewhere.
The Returns On Capital At Cachet Pharmaceutical (SZSE:002462) Don't Inspire Confidence
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment